Skip to main content

Advertisement

Table 1 Basic data

From: Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison

   HC n = 28 PS n = 22 p
Age Mean (SD) 69.8 (4.4) 68.8 (8.0) 0.950
Body weight, kg Mean (SD) 73.4 (10.9) 76.4 (12.8) 0.226
FE-PE2I dosage, MBq Mean (SD) 176.0 (21.5) 165.9 (14.0) 0.120
Olfactory functiona Normal/pathologic 25/3 4/14 < 0.001
Sniff test, pointsa Mean (SD) 10.1 (1.1) 6.5 (2.8) < 0.001
UPDRS-III Median (min-max) 1.0 (0–5) 22.5 (9–33) < 0.001
Symptoms’ duration, years Mean (SD) NA 1.1 (0.8)
H&Y Median (min-max) NA 2 (1–4)
  1. HC healthy controls; PS parkinsonian syndrome; UPDRS-III Unified Parkinson’s Disease Rating Scale, motor part; H&Y Hoehn and Yahr disease stage score; NA not applicable
  2. aOlfactory testing data available for 18 patients